BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37690970)

  • 1. Overall Survival of Metastatic Prostate Cancer Patients According to Location of Visceral Metastatic Sites.
    Tappero S; Piccinelli ML; Incesu RB; Cano Garcia C; Barletta F; Morra S; Scheipner L; Baudo A; Tian Z; Parodi S; Dell'Oglio P; de Cobelli O; Graefen M; Chun FKH; Briganti A; Longo N; Ahyai S; Carmignani L; Saad F; Shariat SF; Suardi N; Borghesi M; Terrone C; Karakiewicz PI
    Clin Genitourin Cancer; 2024 Apr; 22(2):47-55.e2. PubMed ID: 37690970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Significance of Sites of Visceral Metastatic Disease in Prostate Cancer: A Population-based Study of 12,180 Patients.
    Budnik J; Suri J; Bates JE; Bylund KC; Milano MT
    Clin Genitourin Cancer; 2019 Aug; 17(4):260-267. PubMed ID: 31101579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of patients with clear cell renal carcinoma according to number and location of organ-specific metastatic sites.
    Tappero S; Barletta F; Piccinelli ML; Cano Garcia C; Incesu RB; Morra S; Scheipner L; Baudo A; Tian Z; Parodi S; Dell'Oglio P; Briganti A; de Cobelli O; Chun FKH; Graefen M; Longo N; Ahyai S; Carmignani L; Saad F; Shariat SF; Suardi N; Borghesi M; Terrone C; Karakiewicz PI
    Urol Oncol; 2024 Jan; 42(1):22.e23-22.e31. PubMed ID: 37775340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Location of Metastases in Contemporary Prostate Cancer Patients Affects Cancer-Specific Mortality.
    Mazzone E; Preisser F; Nazzani S; Tian Z; Bandini M; Gandaglia G; Fossati N; Soulières D; Graefen M; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    Clin Genitourin Cancer; 2018 Oct; 16(5):376-384.e1. PubMed ID: 29954690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognosis of different distant metastases pattern in prostate cancer: A population based retrospective study.
    Shou J; Zhang Q; Wang S; Zhang D
    Prostate; 2018 May; 78(7):491-497. PubMed ID: 29436722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of prognosis and gene expression in prostate cancer patients with site-specific visceral metastases.
    Zhang P; Chen T; Yang M
    Urol Oncol; 2024 May; 42(5):160.e1-160.e10. PubMed ID: 38433022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of non-regional lymph nodes in assigning risk in primary metastatic prostate cancer.
    Ali A; Hoyle A; Mistry H; Clarke NW
    BJU Int; 2019 Jan; 123(1):65-73. PubMed ID: 29777564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the Site of Metastases on Survival in Patients with Metastatic Prostate Cancer.
    Gandaglia G; Karakiewicz PI; Briganti A; Passoni NM; Schiffmann J; Trudeau V; Graefen M; Montorsi F; Sun M
    Eur Urol; 2015 Aug; 68(2):325-34. PubMed ID: 25108577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer.
    Evans CP; Higano CS; Keane T; Andriole G; Saad F; Iversen P; Miller K; Kim CS; Kimura G; Armstrong AJ; Sternberg CN; Loriot Y; de Bono J; Noonberg SB; Mansbach H; Bhattacharya S; Perabo F; Beer TM; Tombal B
    Eur Urol; 2016 Oct; 70(4):675-683. PubMed ID: 27006332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer.
    Halabi S; Kelly WK; Ma H; Zhou H; Solomon NC; Fizazi K; Tangen CM; Rosenthal M; Petrylak DP; Hussain M; Vogelzang NJ; Thompson IM; Chi KN; de Bono J; Armstrong AJ; Eisenberger MA; Fandi A; Li S; Araujo JC; Logothetis CJ; Quinn DI; Morris MJ; Higano CS; Tannock IF; Small EJ
    J Clin Oncol; 2016 May; 34(14):1652-9. PubMed ID: 26951312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).
    Balch CM; Soong SJ; Murad TM; Smith JW; Maddox WA; Durant JR
    J Clin Oncol; 1983 Feb; 1(2):126-34. PubMed ID: 6668496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical correlates and prognostic value of different metastatic sites in patients with malignant melanoma of the skin: a SEER database analysis.
    Abdel-Rahman O
    J Dermatolog Treat; 2018 Mar; 29(2):176-181. PubMed ID: 28745581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional location of lymph node metastases predicts survival in patients with
    Wang ZP; Chen JR; Zhao JG; Zhu S; Zhang XM; Liang JY; He B; Ni YC; Sun GX; Shen PF; Zeng H
    Asian J Androl; 2023; 25(4):462-467. PubMed ID: 36348577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
    Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
    World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Race and Age on Distribution of Metastases in Patients with Prostate Cancer.
    Stolzenbach LF; Rosiello G; Deuker M; Collà-Ruvolo C; Nocera L; Tian Z; Tilki D; Briganti A; Saad F; Chun FKH; Graefen M; Karakiewicz PI
    J Urol; 2020 Nov; 204(5):962-968. PubMed ID: 32396050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of metastatic pattern in stage IV male breast cancer at initial diagnosis: a population-based study.
    Leone JP; Leone BA; Zwenger AO; Vallejo CT; Romero AO; Machiavelli MR; Pérez JE; Leone J
    Breast Cancer Res Treat; 2021 May; 187(1):237-244. PubMed ID: 33389398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Men with Castration-Resistant Prostate Cancer, Visceral Metastases Predict Shorter Overall Survival: What Predicts Visceral Metastases? Results from the SEARCH Database.
    Whitney CA; Howard LE; Posadas EM; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Freedland SJ
    Eur Urol Focus; 2017 Oct; 3(4-5):480-486. PubMed ID: 28753787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors of developing visceral metastases at diagnosis in prostate cancer patients.
    Xu N; Wu YP; Ke ZB; Liang YC; Tao X; Chen SH; Li XD; Cai H; Lin YZ; Lin TT; Xue XY
    Transl Cancer Res; 2019 Jun; 8(3):928-938. PubMed ID: 35116832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How do organ-specific metastases affect prognosis and surgical treatment for patients with metastatic upper tract urothelial carcinoma: first evidence from population based data.
    Dong F; Fu H; Shi X; Shen Y; Xu T; Gao F; Wang X; Zhong S; Ding Q; Shen Z; Chen S
    Clin Exp Metastasis; 2017 Dec; 34(8):467-477. PubMed ID: 29500709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic importance of concomitant non-regional lymph node and bone metastases in men with newly diagnosed metastatic prostate cancer.
    Heesterman BL; van der Poel HG; Schoots IG; Mehra N; Aben KKH
    BJU Int; 2022 Aug; 130(2):217-225. PubMed ID: 34741789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.